- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
- Paralegals
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
September 28, 2023Robins Kaplan Ranks in Top 10% For Pro Bono By Law360
-
September 25, 2023Jake Holdreith Admitted to American College of Trial Lawyers
-
September 22, 2023Robins Kaplan Attorneys Named 2023 New York Super Lawyers and Rising Stars
-
October 4, 2023Lying, Cheating, and Stealing Seminar 2023
-
October 27, 2023LGBTQ Legal Services: Transgender Name Change Clinic
-
October 26-27, 2023MAJ 2023 New Lawyer Bootcamp
-
September 2023Evenstad Family Trial Aftermath: Rule 408 May Not Be Used as a Sword and Shield
-
September 2023Meet Our Keynote Speaker: Journalist and New York Times Contributor Katie Engelhart
-
September 2023Walking the Razor’s Edge: Client Capacity and the Attorney-Client Relationship
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Read our attorneys' take on the latest news and trends in the legal and business industries.
Generic Launches
Abbreviated New Drug Applications and 505(b)(2) Applications
First Quarter

This chart tracks the date, drug, reference-listed company, applicant, and indications of publicly available drug launches resulting from Abbreviated New Drug Applications and 505(b)(2) Applications.
Reference Listed Drug | ANDA Holder | Generic Drug Name | ANDA Applicant(s) |
Indication | Launch Date |
---|---|---|---|---|---|
Aggrastat | Medicure | tirofiban | Nexus | Used to present early myocardial infarction in adult patients presenting with acute coronary syndromes without ST elevation (NSTE-ACS) with the last episode of chest pain occurring within 12 hours and with ECG changes and/or elevated cardiac enzymes | 1/1/2023 |
Duexis | Horizon | ibuprofen / famotidine | Par / Endo | Used to relieve the signs and symptoms of rheumatoid arthritis and osteoarthritis | 1/3/2023 |
Suboxone | Indivior | buprenorphine / naloxone | Par / Endo | Used to treat opioid dependence |
1/3/2023 |
Xyrem | Jazz | sodium oxybate | Hikma | Used to treat cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy | 1/3/2023 |
Nexavar | Bayer | sorafenib | Teva | Used to treat patients with locally recurrent or metastatic, progressive, differentiated thyroid carcinoma (DTC) that is refractory to radioactive iodine treatment | 1/3/2023 |
Amitiza | Sucampo | lubiprostone | Teva | Used to treat adult patients with chronic idiopathic constipation, or opioid-induced constipation in patients with chronic non-cancer pain | 1/3/2023 |
Flector | IBSA | diclofenac | Yaral | Used to treat pain and inflammation from varying sources including inflammatory conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as injury-related inflammation due to surgery and physical trauma | 1/3/2023 |
Kuvan | Biomarin | sapropterin | Camber / Hetero | Used to reduce blood phenylalanine (Phe) levels in patients with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive Phenylketonuria (PKU) | 1/4/2023 |
Trokendi XR | Supernus | topiramate | Zydus | Used to manage and treat epilepsy and migraine | 1/4/2023 |
Narcan | Emergent | naloxone | Hikma | Used for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression | 1/4/2023 |
Cambia | Assertio | diclofenac | Par / Endo | Used to treat pain and inflammation from varying sources including inflammatory conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as injury-related inflammation due to surgery and physical trauma | 1/5/2023 |
Haloette / NuvaRing | Merck | etonogestrel / ethinyl estradiol | Mayne | Used for the prevention of pregnancy in women who elect to use this product as a method of contraception | 1/13/2023 |
Cambia | Assertio | diclofenac | Camber / Hetero | Used to treat pain and inflammation from varying sources including inflammatory conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as injury-related inflammation due to surgery and physical trauma | 1/14/2023 |
Tenex | Unichem | guanfacine HCL | TWi | Used to treat Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications | 1/23/2023 |
Theophylline | Akorn | theophylline | Teva | Used to prevent and treat wheezing, shortness of breath, and chest tightness caused by asthma, chronic bronchitis, emphysema, and other lung diseases | 1/27/2023 |
Zioptan | Akorn | tafluprost | Prasco | Used to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension | 11/18/2022 |
Lupron Depot | AbbVie | leuprolide acetate | Cipla | Used to manage endometriosis, including pain relief and reduction of endometriotic lesions | 11/29/2022 |
Namenda | Allergan | memantine HCL | Camber / Hetero | Used to treat moderate to severe dementia of the Alzheimer's type | 1/30/2023 |
Doryx MPC | Mayne | doxycycline | Mayne | Used to treat many different bacterial infections including acne, urinary and respiratory tract infections, eye infections, gum disease, gonorrhea, chlamydia, and syphilis. It can also be used prevent malaria and treat infections caused by mites, ticks, or lice | 2/15/2023 |
Cardizem | Bausch | diltiazem | Mayne | Used to treat high blood pressure and to control angina (chest pain) | 2/15/2023 |
Zonalon | Mylan | doxepin | Teva | Used to treat insomnia (difficulty falling asleep or staying asleep) in people who have trouble staying asleep | 2/17/2023 |
Latuda | Sunovion | lurasidone | Lupin | Used to treat schizophrenia in patients ≥13 years old. It is also indicated as a monotherapy for the treatment of bipolar depression in patients ≥10 years old, or in combination with lithium or valproate for the treatment of bipolar depression in adults | 2/21/2023 |
Combigan | AbbVie | brimonidine / timolol | Apotex | Used to treat increased eye pressure from either open-angle glaucoma or ocular hypertension | 2/23/2023 |
Zyprexa Zydis | Eli Lilly | olanzapine | Apotex | Used in the management of schizophrenia, bipolar 1 disorder, and agitation associated with these disorders | 2/24/2023 |
Valcyte | Roche | valganciclovir | Camber / Hetero | Used to treat cytomegalovirus (CMV) retinitis (eye infection that can cause blindness) in people who have acquired immunodeficiency syndrome (AIDS) | 3/1/2023 |
Cystadane | Recordati | betaine | Cosette/ANI | Used to treat homocystinuria in pediatric and adult patients to decrease elevated homocysteine blood levels | 3/2/2023 |
Axiron | Eli Lilly | testosterone | TWi | Used for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone | 3/2/2023 |
Ranexa | Gilead | ranolazine | Camber / Hetero | Used to treat chronic angina | 3/3/2023 |
Bentyl | AbbVie | dicyclomine | Upsher-Smith / CorePharma | Used to treat functional bowel disorder and irritable bowel syndrome | 3/6/2023 |
Revlimid | Celgene | lenalidomide | Teva | Used to treat patients with multiple myeloma (MM) in combination with dexamethasone | 3/8/2023 |
Zyvox | Hetero | linezolid | Camber / Hetero | Used to treat infections, including pneumonia, and infections of the skin | 3/9/2023 |
Revlimid | Celgene | lenalidomide | Natco | Used to treat adult patients with multiple myeloma (MM) in combination with dexamethasone | 3/9/2023 |
Pylera | AbbVie | bismuth subcitrate potassium / metronidazole / tetracycline | Endo | Used to treat ulcers in the stomach caused by the bacteria H. pylori | 3/10/2023 |
Aubagio | Sanofi | teriflunomide | Accord | Used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults | 3/13/2023 |
Aubagio | Sanofi | teriflunomide | Camber / Hetero | Used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults | 3/13/2023 |
Aubagio | Sanofi | teriflunomide | Teva | Used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults | 3/13/2023 |
Lexiscan | Astellas | regadenoson | Apotex | Used as a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress | 3/13/2023 |
Thyro-Tabs | Alvogen | levothyroxine sodium | Camber / Hetero | Used to treat primary, secondary, and tertiary hypothyroidism | 3/21/2023 |
Vascepa | Amarin | icosapent | Hikma | Used to reduce the risk of heart attack, stroke, and certain types of heart problems that require treatment in a hospital | 3/21/2023 |
Protonix | Wyeth | pantoprazole | Camber / Hetero | Used to treat damage from gastroesophageal reflux disease (GERD), a condition in which backward flow of acid from the stomach causes heartburn and possible injury of the esophagus (the tube between the throat and stomach) in adults and children 5 years of age and older | 3/23/2023 |
Adrenalin | Par | epinephrine | American Regent | Used in the emergency treatment of type I allergic reactions, including anaphylaxis | 3/30/2023 |
Trokendi XR | Supernus | topiramate | Teva | Used to manage and treat epilepsy and migraine | 3/31/2023 |
Amicar | Clover | aminocaproic acid | Camber / Hetero | Used to treat excessive postoperative bleeding | 3/31/2023 |
GENERICally Speaking Hatch Waxman Bulletin
GENERICally Speaking Hatch Waxman Bulletin
READ MORE Related Publications
Second Quarter
Generically Speaking: A Hatch-Waxman Litigation Bulletin
Oren Langer, Christopher Pinahs, Emily Tremblay, and Christine May
Second Quarter
ANDA Approvals
GENERICally Speaking Hatch Waxman Bulletin
Second Quarter
ANDA Litigation Settlements
GENERICally Speaking Hatch Waxman Bulletin
Second Quarter
Generic Launches
GENERICally Speaking Hatch Waxman Bulletin
Second Quarter
New ANDA Cases
GENERICally Speaking Hatch Waxman Bulletin
Related News
October 14, 2022
September 9, 2022
Back to Top
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.